+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

R

Actively Recruiting

Researchers are evaluating how well guselkumab works to improve symptoms of psoriatic arthritis, an inflammatory joint disease affecting people with psoriasis, which causes red, scaly skin patches. This observational study uses musculoskeletal ultrasound MSUS to assess disease activity and treatment effects in a real-world setting, focusing on participants with active psoriatic arthritis. Participants with confirmed psoriatic arthritis who are treated with guselkumab according to standard clinical practice are enrolled. No study drug is provided instead, data from routine clinical care, including ultrasound results, are collected. Participants will also answer questions about their health and well-being. The study tracks outcomes such as reductions in synovitis scores, disease activity indices, enthesitis resolution, pain scores, and treatment persistence over periods extending up to 52 weeks. During the study, participants undergo assessments at baseline and at weeks 12, 24, and 52, including ultrasound examinations and clinical evaluations. Researchers measure outcomes like global synovitis scores, disease activity, minimal disease activity achievement, and adverse events. Data collection aligns with routine care visits, allowing long-term monitoring of treatment effects and safety. The study is sponsored by Janssen Research & Development, LLC and runs from December 2025 until June 2028.

Age: 18Years +All Genders
21 locations
E

Actively Recruiting

This research aims to enhance self-management skills for adults with Type 2 Diabetes Mellitus T2DM living in the Marche region of Italy. It evaluates a mobile health m-health solution personalized by diabetologists and integrated with electronic patient records, comparing its use to usual diabetes care. The main goal is to measure changes in glycated haemoglobin HbA1c levels over a 12-month period to assess the effectiveness of this digital support. Participants will be randomly assigned to either a treated group using the m-health solution or a control group receiving regular care. The m-health system includes mobile apps for tracking health data such as blood sugar, physical activity, and diet, sending alerts and motivational messages, allowing communication with healthcare professionals, and providing access to educational materials. Healthcare providers will monitor patient data through an integrated electronic platform. The treatment lasts 12 months with evaluations at baseline, 4, 8, and 12 months. During the study, participants will engage in clinical assessments and complete validated questionnaires covering disease severity, medication adherence, lifestyle habits, self-efficacy, and quality of life. Data will be collected from self-reports, clinical visits, and the m-health app. Researchers will also explore patients experience and satisfaction with the m-health solution and assess its cost-effectiveness. No extra visits or lab tests beyond routine care are required.

Age: 18Years +All GendersPhase Not Applicable
11 locations
S

Actively Recruiting

Obstructive Sleep Apnea OSA is a common sleep-related breathing disorder linked to serious health risks including heart, brain, and metabolic diseases. It has a high prevalence and worsens if untreated, contributing to increased mortality even in mild cases. European studies have shown varied symptoms and complications across regions, but detailed data for the Italian population is lacking. This study aims to better understand OSA in Italy by assessing different physiological and clinical patterns, its association with other health conditions, and creating a long-term patient database. The study collects clinical, sleep study, and treatment data from patients suspected of having OSA at Italian Sleep Centers. A clinical questionnaire will standardize data collection, and a feasibility study on 100 patients will be conducted. Additional tests include EKG, spirometry, blood pressure monitoring, blood chemistry, and assessments of sleepiness, cognitive function, and anxietydepression. A web platform will securely store anonymous patient information. Participants will undergo polysomnography after enrollment to confirm OSA. Data will be collected on apnea-hypopnea index and oxygen saturation at enrollment. Researchers will analyze OSA severity, associated metabolic and cardiovascular risks, and different clinical patterns. The study will develop screening questionnaires and establish a registry for ongoing follow-up to support preventive health strategies in Italy. Participation duration varies, with data collected at enrollment and follow-up planned.

Age: 18Years +All Genders
30 locations